FDA Inspection 999080 — Grifols Bio Supplies Inc

Grifols Bio Supplies Inc — FEI 1049760

The FDA completed an inspection of Grifols Bio Supplies Inc on Oct 14, 2016 in Miami, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Oct 14, 2016
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Miami, FL (United States)

Citations

IDCFRDescription
1806821 CFR 630.5(d)CPR certification
1808221 CFR 630.10(e)(2)Additional Medical Assessment Factors
6721 CFR 606.65(e)Following manufacturer's instructions
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.